Trexquant Investment’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Trexquant Investment’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,827	Closed	-$1.42M	–	1962
2022 Q2	$1.42M	Sell	18,827 -3,066	-14%	-$136K	0.06%	369
2022 Q1	$588K	Buy	+21,893	New	+$736K	0.03%	694
2021 Q2	–	Sell	-8,482	Closed	-$802K	–	1642
2021 Q1	$802K	Buy	+8,482	New	+$1.01M	0.07%	339
2020 Q1	–	Sell	-3,895	Closed	-$243K	–	1523
2019 Q4	$243K	Buy	+3,895	New	+$185K	0.01%	836

Trexquant Investment's TPTX Position: Q3 2022 in Review

Trexquant Investment sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 18,827 shares — an estimated $1.42M sold.

Trexquant Investment first reported a position in TPTX in Q4 2019 and held it in 4 quarters. The position peaked at $1.42M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Trexquant Investment reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Trexquant Investment sold 18,827 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.42M.
Trexquant Investment first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
Trexquant Investment's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.42M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Trexquant Investment's 13F filing for Q3 2022, filed 14 Nov 2022.